A Phase I Dose-Finding Study Of Metformin In Combination With Concurrent Cisplatin And Radiation In Patients With Locally Advanced Head And Neck Squam
Posted Date: May 15, 2019
- Investigator: Trisha Wise-Draper
- Type of Study: Drug
The purpose of this research study is to test the safety of adding metformin to treatment that you will already be getting for your cancer. You will be offered ?standard of care? treatment whether you participate in this study or not. The standard of care treatment will be cisplatin once every 3 w
Criteria:
To Be Eligible To Participate, Patients Must Have Head And Neck Cancer That Requires Treatment With
Keywords:
Head & Neck, Ucci-Hn-14-01, Squamous Cell, Cancer
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu